Maximum tumor diameters (MTDs) were significantly smaller in the transplant compared with the non-transplant group (median MTD was 2.5 cm versus 6.5 cm) and the median serum AFP levels were lower (median 9.6 versus 38.5 IU/mL) and the percent of patients with portal vein thrombosis (PVT) was also much lower (21.3% versus 46.3% of patients) in the transplant versus the non-transplant treatment groups. Here, AFP is linked to Portal vein thrombosis.